On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Advertising disclosure: When you use our links to explore or buy products we may earn a fee, but that in no way affects our editorial independence. Don't leave your business vulnerable after a policy ...

Meagan is a former Series 7 financial advisor and current writer focused on blending straightforward information with a dose of humor on topics including equity investments, insurance products, and ...

A single-author repo of instruction files, not code, Ponytail passed 44,000 GitHub stars in nine days by making coding agents ...

All the Latest Game Footage and Images from Night Tail There are monsters in the world that devours human memory and spirit, called dream monster. The protagonist, Yoru, has the power to fight against ...

Use Spring MVC MultipartFile, Java Path APIs and the browser fetch API to upload files asynchronously and save them safely on the server. Learn how JAR files relate to ZIP archives, how to extract ...

Recursion Pharmaceuticals reported mixed Q2 results, with revenues dropping to $7.67 million from last year’s $19.22 million. The company continues to make progress with its AI-driven drug discovery, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...